terazosin has been researched along with Chronic Disease in 12 studies
Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the efficacy of levofloxacin, terazosin, and their combination in patients with category III chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)." | 9.22 | A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. ( Liang, K; Wang, J; Xu, Z; Yan, D, 2016) |
| "To investigate the efficacy and safety of the alpha1-receptor inhibitor terazosin combined with chlormezanone in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)." | 9.14 | [Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome]. ( Li, HJ; Li, HZ; Yan, S; Zhang, XY, 2009) |
| "To evaluate the clinical efficacy and safety of dexketoprofen trometamol in the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)." | 9.14 | [Dexketoprofen trometamol in the treatment of chronic prostatitis/chronic pelvic pain syndrome]. ( Jiang, MH; Liu, HL; Wu, GC, 2009) |
| "To evaluate the initial, long-term, and durable response rates to terazosin, placebo, or other therapies in patients with chronic prostatitis/chronic pelvic pain syndrome." | 9.11 | Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. ( Cheah, PY; Khor, T; Krieger, JN; Liong, ML; Teh, CL; Yang, JR; Yap, HW; Yuen, KH, 2004) |
| "We evaluate terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome." | 9.10 | Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. ( Cheah, PY; Khor, T; Krieger, JN; Liong, ML; Teh, CL; Yang, JR; Yap, HW; Yuen, KH, 2003) |
| "Terazosine was effective for the treatment of CPPS." | 6.70 | Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index. ( Eroğlu, M; Gül, O; Ozok, U, 2001) |
| "To explore the efficacy of levofloxacin, terazosin, and their combination in patients with category III chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)." | 5.22 | A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. ( Liang, K; Wang, J; Xu, Z; Yan, D, 2016) |
| "We obtained NIH-CPSI and IIEF-5 scores from 132 chronic prostatitis patients with ED and divided the patients into a control (n = 70) and a treatment group (n = 62), the former treated with oral levofloxacin 0." | 5.16 | [Efficacy of compound Xuanju capsule in the treatment of chronic prostatitis with erectile dysfunction]. ( Chao, WF; Huang, XK; Liang, P; Liu, JW; Wang, L; Wang, QT; Yang, H; Yang, W; Zhou, P, 2012) |
| "To investigate the efficacy and safety of the alpha1-receptor inhibitor terazosin combined with chlormezanone in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)." | 5.14 | [Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome]. ( Li, HJ; Li, HZ; Yan, S; Zhang, XY, 2009) |
| "To evaluate the clinical efficacy and safety of dexketoprofen trometamol in the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)." | 5.14 | [Dexketoprofen trometamol in the treatment of chronic prostatitis/chronic pelvic pain syndrome]. ( Jiang, MH; Liu, HL; Wu, GC, 2009) |
| "To evaluate the initial, long-term, and durable response rates to terazosin, placebo, or other therapies in patients with chronic prostatitis/chronic pelvic pain syndrome." | 5.11 | Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. ( Cheah, PY; Khor, T; Krieger, JN; Liong, ML; Teh, CL; Yang, JR; Yap, HW; Yuen, KH, 2004) |
| "We evaluate terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome." | 5.10 | Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. ( Cheah, PY; Khor, T; Krieger, JN; Liong, ML; Teh, CL; Yang, JR; Yap, HW; Yuen, KH, 2003) |
| "Terazosine was effective for the treatment of CPPS." | 2.70 | Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index. ( Eroğlu, M; Gül, O; Ozok, U, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, XY | 2 |
| Luo, SB | 1 |
| Zhang, JY | 1 |
| Meng, ZC | 1 |
| Wang, J | 2 |
| Yan, D | 1 |
| Liang, K | 1 |
| Xu, Z | 1 |
| Yan, S | 1 |
| Li, HZ | 1 |
| Li, HJ | 1 |
| Jiang, MH | 1 |
| Wu, GC | 1 |
| Liu, HL | 1 |
| Wang, L | 1 |
| Liang, P | 1 |
| Yang, W | 1 |
| Zhou, P | 1 |
| Huang, XK | 1 |
| Liu, JW | 1 |
| Chao, WF | 1 |
| Yang, H | 1 |
| Wang, QT | 1 |
| Li, J | 1 |
| Lu, R | 1 |
| Wang, JM | 1 |
| Cheah, PY | 2 |
| Liong, ML | 2 |
| Yuen, KH | 2 |
| Teh, CL | 2 |
| Khor, T | 2 |
| Yang, JR | 2 |
| Yap, HW | 2 |
| Krieger, JN | 2 |
| Minervini, A | 1 |
| Lapini, A | 1 |
| Serni, S | 1 |
| Carini, M | 1 |
| Paterna, S | 1 |
| Martino, S | 1 |
| Ingurgio, NC | 1 |
| Arrostuto, A | 1 |
| Correo, S | 1 |
| Licata, G | 1 |
| Drabick, JJ | 1 |
| Gambel, JM | 1 |
| Mackey, JF | 1 |
| Gül, O | 1 |
| Eroğlu, M | 1 |
| Ozok, U | 1 |
10 trials available for terazosin and Chronic Disease
| Article | Year |
|---|---|
[Triple acupuncture at the Qugu acupoint as an adjunctive therapy for type-Ⅲ chronic prostatitis: Analysis of short- and long-term clinical effects].
Topics: Acupuncture Points; Acupuncture Therapy; Anti-Bacterial Agents; Chronic Disease; Chronic Pain; Combi | 2017 |
A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Chronic Disease; Drug Therapy, Combination; Huma | 2016 |
[Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome].
Topics: Adult; Chlormezanone; Chronic Disease; Drug Therapy, Combination; Humans; Male; Middle Aged; Pain Me | 2009 |
[Dexketoprofen trometamol in the treatment of chronic prostatitis/chronic pelvic pain syndrome].
Topics: Adult; Chronic Disease; Humans; Indomethacin; Ketoprofen; Male; Pelvic Pain; Prazosin; Prostatitis; | 2009 |
[Efficacy of compound Xuanju capsule in the treatment of chronic prostatitis with erectile dysfunction].
Topics: Adult; Capsules; Chronic Disease; Drugs, Chinese Herbal; Erectile Dysfunction; Humans; Levofloxacin; | 2012 |
[Treatment of external RF hyperthermia combining with alpha 1-adrenergic receptor blocker for patients with prostatodynia and chronic non-bacterial prostatitis].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Chronic Disease; Combi | 2002 |
Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
Topics: Adrenergic alpha-Antagonists; Adult; Chronic Disease; Humans; Male; Middle Aged; Pelvic Pain; Prazos | 2003 |
Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.
Topics: Adrenergic alpha-Antagonists; Adult; Chronic Disease; Double-Blind Method; Follow-Up Studies; Humans | 2004 |
[The effects of terazosin hydrochloride and buflomedil in patients with hemicrania without aura].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Chronic Disease; Drug Therapy, Combination; Female; | 1994 |
Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Chronic Disease; Humans; Male; Middle Aged; Prazosi | 2001 |
2 other studies available for terazosin and Chronic Disease
| Article | Year |
|---|---|
Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.
Topics: Chronic Disease; Humans; Male; Pelvic Pain; Prazosin; Prostatitis; Syndrome; Time Factors | 2005 |
Prostatodynia in United Nations peacekeeping forces in Haiti.
Topics: Abscess; Adrenergic alpha-Antagonists; Adult; Age Factors; Anti-Bacterial Agents; Chronic Disease; C | 1997 |